Olive Leaf Extract: Oleuropein, Benefits, Dosage and Safety
Olive leaf extract sits between a long herbal tradition and modern cardiometabolic research. The leaves contain phenolic compounds, especially oleuropein, that make the extract easy to standardize. But a precise label number does not prove a blood-pressure, cholesterol or glucose outcome.
This guide starts with what Biogénique Olive Leaf Extract is licensed to do in Canada, then explains the evidence, 20% oleuropein statement, correct dose, “occasional use” direction and relevant quality documentation.
Quick Answer
|
Biogénique Olive Leaf Extract provides 300 mg of Olea europaea leaf extract per capsule, equivalent to 3 g of dried leaf and standardized to 20% oleuropein. NPN 80133826 authorizes it as a source of antioxidants and for use in Herbal Medicine as a diuretic. Adults take one capsule once daily with food, for occasional use only. Research on blood pressure and other cardiometabolic outcomes is mixed and does not expand those licensed uses. |
What is olive leaf extract?
Olive leaf extract is made from the leaves of Olea europaea, the same species that produces olives and olive oil. It is not the same as olive oil: the source material, composition and usual doses differ. Olive leaf contains several phenolic compounds; oleuropein is the best-known and is often used as a standardization marker.
Standardization helps make the label more informative. A raw-herb amount tells you how much plant material was used, while an extract statement can also identify the equivalent amount of dried leaf and a target level of a marker compound. Those details improve comparability, but they do not show that every batch was independently tested or that the finished product delivers a particular clinical result.
What does 20% oleuropein mean?
The current formula lists 300 mg of extract standardized to 20% oleuropein. Mathematically, 20% of 300 mg is approximately 60 mg of oleuropein per capsule. That calculation explains the label; it is not a separate assay result and should not be represented as proof of the content of a specific lot.
The extract is also listed as equivalent to 3 g of dried olive leaf, which indicates a 10:1 relationship between dried plant material and extract weight. Health Canada’s current Olive Leaf monograph allows standardized ethanolic extracts equivalent to no more than 3.5 g of dried leaf daily and containing no more than 20.8% oleuropein. The licensed Biogénique daily dose—3 g dried-leaf equivalent at 20% oleuropein—fits within those monograph parameters.
What benefits are licensed in Canada?
Two uses are authorized for this exact product: it is a source of antioxidants and is used in Herbal Medicine as a diuretic. The antioxidant wording should not be stretched into a promise to prevent disease, slow ageing or cause a noticeable change.
A diuretic increases urine production. This traditional-use claim does not make the product equivalent to prescription therapy or appropriate for self-treating swelling, kidney disease or high blood pressure. Persistent swelling, shortness of breath, sudden weight gain or reduced urination requires medical assessment.
What does the human research show?
Olive leaf extracts have been studied for blood pressure, lipids and glucose regulation, but extracts, doses and populations vary. A 2024 systematic review and meta-analysis reported possible improvements in some cardiometabolic risk factors while noting heterogeneity and a small evidence base. A pooled estimate does not prove that every product works the same way.
A 2021 systematic review also found signals for lower systolic blood pressure in a small subset of trials, including studies using 500 mg daily. Qualifying trials were limited and their preparations differed; some older studies also lacked a placebo comparison.
A useful counterweight is a 2026 randomized, double-blind, placebo-controlled trial in 56 adults with elevated systolic blood pressure. Participants received a combined olive extract providing 334 mg of olive leaf standardized to 100 mg oleuropein plus 106 mg of olive fruit standardized to 20 mg hydroxytyrosol daily for eight weeks. Systolic blood pressure declined in both groups, with no significant difference from placebo, and lipid changes were not significant. The small study tested a combination unlike this product, but its neutral result reinforces why certainty is not justified.
The responsible conclusion is therefore modest: olive leaf research is active and biologically plausible, but cardiovascular and metabolic benefits remain uncertain and formulation-specific. Biogénique Olive Leaf Extract is not licensed to treat hypertension, diabetes, high cholesterol or cardiovascular disease. Never stop or reduce prescribed medication based on a supplement study.
What does the Biogénique formula provide?
The product-specific Natural Product Licence and current label identify one medicinal ingredient and a simple adult schedule:
|
Medicinal ingredient |
Per capsule |
Licensed adult dose |
|
Olea europaea leaf extract (10:1), standardized to 20% oleuropein |
300 mg; equivalent to 3 g dried leaf |
1 capsule once daily with food |
Adults 18+. For occasional use only. Product licence NPN 80133826, issued 27 August 2024.
Dose, timing and duration
Adults take one capsule once daily with food. Food is not merely a convenience suggestion: it appears in both the product licence and Health Canada’s Olive Leaf monograph. The authorized duration statement is “for occasional use only.” That means this label does not support indefinite daily use unless a qualified healthcare professional has reviewed the reason, duration, medicines and relevant health conditions.
Do not increase the dose in an attempt to reproduce a study result. Research doses cannot be compared by capsule weight alone because oleuropein content, extraction method and accompanying ingredients differ. The correct reference for this product is its current label, not the dose used in a trial of another extract.
How to decide whether it fits your routine
-
Match the goal to the licence. Choose it for the authorized antioxidant or Herbal Medicine diuretic context—not as a self-directed treatment for blood pressure, blood sugar, cholesterol or fluid retention.
-
Read the standardization. This capsule supplies 300 mg of extract at 20% oleuropein, equivalent to 3 g of dried leaf. Compare all three facts when evaluating alternatives.
-
Respect the duration. The licensed direction says occasional use only. A plan for continuous daily use deserves professional review.
-
Check medicines and conditions. Kidney disorders and other diuretics are explicit reasons to consult a healthcare professional before use.
-
Separate label facts from study findings. A trial using a different extract, oleuropein amount or combination cannot establish the effect of this finished product.
Safety and when to seek advice
Consult a healthcare professional before use if you are pregnant or breastfeeding, have a kidney disorder, or take other diuretics. A diuretic effect may occur. Increased urination can affect hydration, so do not casually combine this supplement with other water pills.
People using blood-pressure or glucose-lowering medicines should also discuss the product with a pharmacist or prescriber. That advice is a prudent inference from the research context, not a claim that an interaction will occur.
Quality, standardization and the missing COA
The issued Natural Product Licence verifies the NPN, ingredient, amount, standardization, dried-leaf equivalent, dose, authorized uses and cautions. Standardization to 20% oleuropein gives buyers a useful specification beyond a generic “olive leaf” amount.
No lot-specific Certificate of Analysis was located in the available Biogénique records or on the product page. An invoice referenced testing and a planned COA, but it is not a test report and cannot substantiate a passed batch. This article therefore makes no lot-specific claim about identity, oleuropein assay, microbial limits, heavy metals, purity or disintegration.
A useful COA should identify the product and lot, dates, specifications and results for identity and oleuropein content. It may also report microbiological limits and elemental contaminants. The lot number should connect the report to the bottle.
Frequently Asked Questions
How much oleuropein is in one capsule?
The label states 300 mg of extract standardized to 20% oleuropein. That equals approximately 60 mg by calculation. Treat this as a label-derived estimate, not a lot-specific laboratory result.
Is olive leaf extract the same as olive oil?
No. Olive leaf extract comes from the leaf and is standardized here to oleuropein. Olive oil is pressed from the fruit and has a different nutrient and phenolic profile. Evidence for olive oil should not be transferred to an olive leaf capsule.
Can olive leaf extract lower blood pressure?
Some trials and meta-analyses suggest possible effects, while a 2026 placebo-controlled trial of a combined olive extract did not confirm a significant benefit. The evidence is mixed, and this product is not licensed to treat high blood pressure. Do not replace or alter medication.
Can I take it every day?
The licensed direction is one capsule daily with food for occasional use only. Ask a qualified healthcare professional before extending use beyond that label context.
Who should consult a healthcare professional first?
People who are pregnant or breastfeeding, have a kidney disorder, or take other diuretics should consult before use. A pharmacist can also review the product alongside blood-pressure or glucose-lowering medicines.
Bottom Line
Biogénique Olive Leaf Extract is a clearly standardized formula: 300 mg of extract, equivalent to 3 g of dried leaf, at 20% oleuropein. Its licensed role is equally clear—a source of antioxidants and an Herbal Medicine diuretic for occasional use. Human cardiometabolic research is interesting but mixed, and it should not be converted into a treatment promise. Use the current label, respect the once-daily-with-food direction and safety cautions, and ask for batch documentation when lot-specific quality matters.
Next step: review the formula, directions and current label on the Biogénique Olive Leaf Extract product page. If you are comparing products, use the licensed claim and standardization—not the longest list of unlicensed promises—as your filter.
Related Resources
-
Olive Leaf Extract product page: Current formula, label directions and purchase information.
-
Biogénique Quality Control: The company’s general quality-control overview; not a lot-specific COA.
-
Health Canada Licensed Natural Health Products Database: Public product-licence record for NPN 80133826.
Evidence & Compliance Note
Product-specific wording follows the current label and Natural Product Licence for NPN 80133826. The December 2025 Health Canada Olive Leaf monograph and June 2026 Antioxidants monograph were checked as supporting claim, dose and safety context; they do not override the issued licence. Clinical research summarized here concerns other olive leaf or combined olive extracts and does not establish additional authorized uses for this product. No product-specific human trial or lot-specific COA was located.
References
1. Health Canada — Licensed Natural Health Products Database: NPN 80133826 — Biogénique Olive Leaf Extract. Current licence and internal regulatory record checked 19 August 2026; licence issued 27 August 2024.
2. Health Canada — Olive Leaf (Olea europaea) monograph — Monograph dated 19 December 2025; antioxidant and diuretic claim context, dose parameters, directions and cautions.
3. Health Canada — Licensed Natural Health Products Database overview — Official database scope and update information.
4. Olive leaf extract effect on cardiometabolic risk factors: systematic review and meta-analysis — Systematic review and meta-analysis of randomized controlled trials, 2024.
5. Effects of olive leaf extract on cardiometabolic risk factors: systematic review and meta-analysis — Systematic review and meta-analysis, 2021; limited and heterogeneous trial evidence.
6. Efficacy of a combined olive leaf and fruit extract on blood pressure and blood lipids — Randomized, double-blind, placebo-controlled trial. PLOS ONE, 10 March 2026.
7. Olive leaf polyphenols and insulin sensitivity in middle-aged overweight men — Randomized placebo-controlled crossover trial, 2013; ingredient-level evidence from a different extract and dose.
8. Biogénique — Olive Leaf Extract — Current consumer product page checked 19 August 2026.
Disclaimer
This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure or prevent disease. Natural health products can cause side effects or interact with medicines. Read the label and consult a qualified healthcare professional when you are pregnant or breastfeeding, have a medical condition, take medication, or are unsure whether this product is appropriate for you.